RecruitingPhase 3NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Sponsor: Pfizer
Anaheim, CA · Camarillo, CA · Fountain Valley, CA · +212 more sites